Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma

被引：0
作者：
Hanauske, AR
Schilling, T
Heinrich, B
Kau, R
Herzog, M
Quasthoff, S
Bochtler, H
Diergarten, K
Rastetter, J
机构：
[1] TECH UNIV MUNICH,KLINIKUM RECHTS ISAR,DEPT OTORHINOLARYNGOL,D-81675 MUNICH,GERMANY
[2] TECH UNIV MUNICH,KLINIKUM RECHTS ISAR,DEPT FACIAL SURG,D-81675 MUNICH,GERMANY
[3] TECH UNIV MUNICH,KLINIKUM RECHTS ISAR,DEPT NEUROL,D-81675 MUNICH,GERMANY
[4] BRISTOL MYERS SQUIBB CO,MUNICH,GERMANY
来源：
SEMINARS IN ONCOLOGY | 1995年 / 22卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：35 / 39
页数：5
相关论文
共 19 条
[1]   CISPLATIN, 5-FLUOROURACIL AND INTERFERON-ALPHA-2B FOR RECURRENT OR METASTATIC HEAD AND NECK-CANCER [J].
CASCINU, S ;
FEDELI, A ;
FEDELI, SL ;
CATALANO, G .
BRITISH JOURNAL OF CANCER, 1994, 69 (02) :392-393
[2]   DOCETAXEL (TAXOTERE(R)) - AN ACTIVE-DRUG FOR THE TREATMENT OF PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
CATIMEL, G ;
VERWEIJ, J ;
MATTIJSSEN, V ;
HANAUSKE, A ;
PICCART, M ;
WANDERS, J ;
FRANKLIN, H ;
LEBAIL, N ;
CLAVEL, M ;
KAYE, SB .
ANNALS OF ONCOLOGY, 1994, 5 (06) :533-537
[3]   A PHASE-II STUDY OF GEMCITABINE (LY-188011) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
CATIMEL, G ;
VERMORKEN, JB ;
CLAVEL, M ;
DEMULDER, P ;
JUDSON, I ;
SESSA, C ;
PICCART, M ;
BRUNTSCH, U ;
VERWEIJ, J ;
WANDERS, J ;
FRANKLIN, H ;
KAYE, SB .
ANNALS OF ONCOLOGY, 1994, 5 (06) :543-547
[4]   RANDOMIZED COMPARISON OF CISPLATIN, METHOTREXATE, BLEOMYCIN AND VINCRISTINE (CABO) VERSUS CISPLATIN AND 5-FLUOROURACIL (CF) VERSUS CISPLATIN (C) IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-III STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP [J].
CLAVEL, M ;
VERMORKEN, JB ;
COGNETTI, F ;
CAPPELAERE, P ;
DEMULDER, PHM ;
SCHORNAGEL, JH ;
TUENI, EA ;
VERWEIJ, J ;
WILDIERS, J ;
CLERICO, M ;
DALESIO, O ;
KIRKPATRICK, A ;
SNOW, GB .
ANNALS OF ONCOLOGY, 1994, 5 (06) :521-526
[5]   A PHASE-II STUDY OF PIRARUBICIN IN PATIENTS WITH ADVANCED RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA [J].
DEMULDER, PHM ;
CAPPELAERE, P ;
COGNETTI, F ;
VERWEIJ, J ;
SCHORNAGEL, JH ;
VERMORKEN, JB ;
KIRKPATRICK, A ;
LEFEBVRE, JL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (05) :438-440
[6]  
FORASTIERE AA, 1994, SEMIN ONCOL, V21, P49
[7]  
HILL BT, 1994, AM J CLIN ONCOL-CANC, V17, P1
[8]   A PHASE-III RANDOMIZED STUDY COMPARING CISPLATIN AND FLUOROURACIL AS SINGLE AGENTS AND IN COMBINATION FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
JACOBS, C ;
LYMAN, G ;
VELEZGARCIA, E ;
SRIDHAR, KS ;
KNIGHT, W ;
HOCHSTER, H ;
GOODNOUGH, LT ;
MORTIMER, JE ;
EINHORN, LH ;
SCHACTER, L ;
CHERNG, N ;
DALTON, T ;
BURROUGHS, J ;
ROZENCWEIG, M .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :257-263
[9]   SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND TAXOL IN HUMAN OVARIAN-CARCINOMA CELLS IN-VITRO [J].
JEKUNEN, AP ;
CHRISTEN, RD ;
SHALINSKY, DR ;
HOWELL, SB .
BRITISH JOURNAL OF CANCER, 1994, 69 (02) :299-306
[10]   METASTATIC PATTERNS IN SQUAMOUS-CELL CANCER OF THE HEAD AND NECK [J].
KOTWALL, C ;
SAKO, K ;
RAZACK, MS ;
RAO, U ;
BAKAMJIAN, V ;
SHEDD, DP .
AMERICAN JOURNAL OF SURGERY, 1987, 154 (04) :439-442
12